Similar articles

• Phase II investigation of pentostatin in multiple myeloma: a Southwest Oncology Group study.

  Grever MR, Crowley J, Salmon S, McGee R, Kraut EH, Buys SS, Rivkin SE. Grever MR, et al. J Natl Cancer Inst. 1990 Nov 21;82(22):1778-9. doi: 10.1093/jnci/82.22.1778. J Natl Cancer Inst. 1990. PMID: 2231774 Clinical Trial. No abstract available.
• Pentostatin and rituximab in the treatment of patients with B-cell malignancies.

  Drapkin R. Drapkin R. Oncology (Williston Park). 2000 Jun;14(6 Suppl 2):25-9. Oncology (Williston Park). 2000. PMID: 10887641
• Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.

  Foss FM. Foss FM. Semin Oncol. 2000 Apr;27(2 Suppl 5):58-63. Semin Oncol. 2000. PMID: 10877054
• Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.

  Spiers AS. Spiers AS. Haematologia (Budap). 1996;27(2):55-84. Haematologia (Budap). 1996. PMID: 14651224 Review.
• [Clinical pharmacology of pentostatin].

  Robak T. Robak T. Pol Tyg Lek. 1990 May 21-28;45(21-22):435-8. Pol Tyg Lek. 1990. PMID: 2267194 Review. Polish. No abstract available.